PolyMedix has a comprehensive computational platform which possesses a wide range of capabilities, from generating proprietary crystal target structures of transmembrane-bound protein receptors, to novel in silico de novo drug design of biomimetics: small molecule compounds that mimic the activity of proteins.

return to top ^